|
 Printable Version
|
FDA Advisory Panel Votes to Keep Avandia on the Market; Society Offers Testimony
In a public hearing held on July 30, 2007, a joint panel of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee voted 22-1 to recommend to the U.S. Food and Drug Administration (FDA) that the diabetes drug Avandia (rosiglitazone) be kept on the market with the addition of a black box warning for specific subgroups of patients.
| President Shupnik Represents Society at NIH Peer Review Working Group Meeting
Society President Margaret Shupnik, PhD, attended a July 30 meeting of leaders in the scientific community to discuss the process of peer review at the National Institutes of Health (NIH).
| Endocrine Society Leaders Invite Collaboration from Sister Societies
On Thursday, July 26, The Endocrine Society co-hosted the fifth annual Sister Society Forum with the American Thyroid Association (ATA). Endocrine Society President, Peggy Shupnik, PhD, co-chaired the meeting with ATA President David Cooper, MD.
| House Approves NIH Funding Measure
The U.S. House of Representatives passed the FY 2008 Labor-Health and Human Services (HHS)-Education appropriations bill, which outlines funding allocations for the National Institutes of Health (NIH), on July 19, 2007 by a vote of 276-140. The bill provides NIH with a $750 million increase (2.6 percent) over FY 2007 levels.
| |
|
